peramivir
Medicine & Life Sciences
100%
Oseltamivir
Medicine & Life Sciences
79%
Zoledronic Acid
Medicine & Life Sciences
76%
Interleukin-6
Medicine & Life Sciences
63%
Pneumonia
Medicine & Life Sciences
63%
Non-alcoholic Fatty Liver Disease
Medicine & Life Sciences
62%
Fatty Liver
Medicine & Life Sciences
62%
Taiwan
Medicine & Life Sciences
57%
Ko, H. W. ,
Shie, S. S. ,
Wang, C. W. ,
Chiu, C. T. ,
Wang, C. L. ,
Yang, T. Y. ,
Chou, S. C. ,
Liu, C. Y. ,
Kuo, C. H. S. ,
Lin, Y. C. ,
Li, L. F. ,
Yang, C. T. &
Wang, C. C. ,
10月 2022 ,
於: Frontiers in Immunology. 13 , 1011092.
研究成果: 雜誌貢獻 › 文章 › 同行評審
ErbB Receptors
100%
Non-Small Cell Lung Carcinoma
93%
Smoking
76%
Mutation
58%
Smokers
26%
Fang, Y. H. ,
Hsu, T. H. ,
Lin, T. Y. ,
Liu, C. H. ,
Chou, S. C. ,
Wu, J. Y. &
Perng, P. C. ,
2021 ,
於: Expert Review of Anti-Infective Therapy. 19 ,
8 ,
p. 1039-1046 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
peramivir
100%
Oseltamivir
79%
Human Influenza
53%
Meta-Analysis
43%
Randomized Controlled Trials
39%
Interleukin-10
100%
C-Reactive Protein
99%
Single Nucleotide Polymorphism
94%
Pneumonia
90%
Interleukin-6
86%
Tsai, C. Y. ,
Chou, S. C. ,
Liu, H. T. ,
Lin, J. D. &
Lin, Y-C. ,
2014 ,
於: Oncology Letters. 8 ,
4 ,
p. 1810-1814 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hypoglycemia
100%
Hepatocellular Carcinoma
83%
Systematic Reviews
76%
Insulinoma
21%
Unconsciousness
20%
Zoledronic Acid
100%
Autophagy
73%
Uterine Cervical Neoplasms
70%
Apoptosis
46%
Cyclooxygenase 2
32%